Form D · Biotechnology

IGY Immune Technologies & Life Sciences Inc.

Thunder Bay, A6 · CIK 0001482985

Offering snapshot reported Feb 22, 2012 · SEC filing

Reported sold
$65.1K
Offering amount: $1M
Investors reported
2
Form D · investor count
Minimum accepted
$15K
Reported outside-investor minimum
First sale
Sep 19, 2011
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$32.6K$65.1KSep 23, 2011: $30,000.00Sep 23, 2011Feb 22, 2012: $65,100.00Feb 22, 2012

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$30,000 → $65,100

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Feb 22, 2012Amendment$65,100$35,100vs Sep 23, 20112SEC filing
Sep 23, 2011Initial$30,000No comparison2SEC filing

Offering details

Securities
Equity, Option to acquire
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-166324

Source: Form D, filed Feb 22, 2012. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Terry Dyck Director, Executive
Sharad Mistry Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
40 S Cumberland Street
Thunder Bay, A6, P7B 2T5